Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Invest Radiol ; 52(10): 620-630, 2017 10.
Artículo en Inglés | MEDLINE | ID: mdl-28598900

RESUMEN

OBJECTIVES: Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) is a method to heat lesions noninvasively to a stable, elevated temperature and a well-suited method to induce local hyperthermia (41°C-43°C) in deep-seated tissues. Magnetic Resonance (MR) imaging provides therapy planning on anatomical images and offers temperature feedback based on near-real-time MR thermometry. Although constant acquisition of MR thermometry data is crucial to ensure prolonged hyperthermia, it limits the freedom to perform measurements of other MR parameters, which are of interest during hyperthermia treatments. In image-guided drug delivery applications, co-encapsulation of paramagnetic MR contrast agents with a drug inside temperature-sensitive liposomes (TSLs) allows to visualize hyperthermia-triggered drug delivery through changes of the longitudinal relaxation rate R1. While the drug accumulates in the heated tumor tissue, R1 changes can be used for an estimate of the tumor drug concentration. The main objective of this study was to demonstrate that interleaved MR sequences are able to monitor temperature with an adequate temporal resolution and could give a reasonable estimate of the achieved tumor drug concentration through R1 changes. To this aim, in vitro validation tests and an in vivo proof-of-concept study were performed. MATERIALS AND METHODS: All experiments were performed on a clinical 3-T MR-HIFU system adapted with a preclinical setup. The validity of the R1 values and the temperature maps stability were evaluated in phantom experiments and in ex vivo porcine muscle tissue. In vivo experiments were performed on rats bearing a 9L glioma tumor on their hind limb. All animals (n = 4 HIFU-treated, n = 4 no HIFU) were injected intravenously with TSLs co-encapsulating doxorubicin and gadoteridol as contrast agent. The TSL injection was followed by either 2 times 15 minutes of MR-HIFU-induced hyperthermia or a sham treatment. R1 maps were acquired before, during, and after sonication, using a single slice Inversion Recovery Look-Locker (IR-LL) sequence (field of view [FOV], 50 × 69 mm; in-plane resolution, 0.52 × 0.71 mm; slice thickness, 3 mm; 23 phases of 130 milliseconds; 1 full R1 map every 2 minutes). The R1 maps acquired during treatment were interleaved with 2 perpendicular proton resonance frequency shift (PRFS) MR thermometry slices (dynamic repetition time, 8.6 seconds; FOV, 250 × 250 mm; 1.4 × 1.4 mm in-plane resolution; 4 mm slice thickness). Tumor doxorubicin concentrations were determined fluorometrically. RESULTS: In vitro results showed a slight but consistent overestimation of the measured R1 values compared with calibrated R1 values, regardless whether the R1 was acquired with noninterleaved IR-LL or interleaved. The average treatment cell temperature had a slightly higher temporal standard deviation for the interleaved PRFS sequence compared with the noninterleaved PRFS sequence (0.186°C vs 0.101°C, respectively). The prolonged time in between temperature maps due to the interleaved IR-LL sequence did not degrade the temperature stability during MR-HIFU treatment (Taverage = 40.9°C ± 0.3°C). Upon heat treatment, some tumors showed an R1 increase in a large part of the tumor while other tumors hardly showed any ΔR1. The tumor doxorubicin concentration showed a linear correlation with the average ΔR1 during both sonications (n = 8, Radj = 0.933), which was higher than for the ΔR1 measured after tumor cooldown (averaged for both sonications, n = 8, Radj = 0.877). CONCLUSIONS: The new approach of interleaving different MR sequences was applied to simultaneously acquire R1 maps and PRFS thermometry scans during a feedback-controlled MR-HIFU-induced hyperthermia treatment. Interleaved acquisition did not compromise speed or accuracy of each scan. The ΔR1 acquired during treatment was used to visualize and quantify hyperthermia-triggered release of gadoteridol from TSLs and better reflected the intratumoral doxorubicin concentrations than the ΔR1 measured after cooldown of the tumor, exemplifying the benefit of interleaving R1 maps with temperature maps during drug delivery. Our study serves as an example for interleaved MR acquisition schemes, which introduce a higher flexibility in speed, sequence optimization, and timing.


Asunto(s)
Glioma/diagnóstico por imagen , Glioma/cirugía , Ultrasonido Enfocado de Alta Intensidad de Ablación/métodos , Hipertermia Inducida/métodos , Imagen por Resonancia Magnética Intervencional/métodos , Animales , Medios de Contraste/administración & dosificación , Modelos Animales de Enfermedad , Doxorrubicina/administración & dosificación , Sistemas de Liberación de Medicamentos/métodos , Gadolinio , Compuestos Heterocíclicos , Aumento de la Imagen/métodos , Liposomas , Compuestos Organometálicos , Ratas , Porcinos , Temperatura
2.
Radiology ; 233(3): 774-80, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15498900

RESUMEN

PURPOSE: To evaluate resonant circuits as markers for magnetic resonance (MR) imaging-guided placement of nitinol stents. MATERIALS AND METHODS: The study was approved by the institutional animal research committee and complied with National Institutes of Health guidelines for care and use of laboratory animals. Resonant circuits similar to catheter markers used at conventional angiography were placed proximally and distally to a nitinol stent in a stent delivery system. Resonant circuits were tested in vitro and in vivo for signal intensity levels that would enable visualization during MR imaging-guided stent deployment. Experiments were conducted by using real-time imaging with a 1.5-T unit. Stents (n = 9) were deployed in the vena cava (n = 2), abdominal aorta (n = 2), isthmus of the aorta (n = 2), and carotid (n = 2) and iliac (n = 1) arteries in five pigs. After intervention, the site of the stent was investigated with balanced fast field-echo MR imaging and contrast material-enhanced MR angiography. Blood flow velocities were measured in the stent lumen and next to the stent with velocity-encoded cine MR imaging. Level of agreement was determined with Bland-Altman analysis. RESULTS: During all interventions, resonant circuits provided highly visible MR signal that allowed fast and reliable visualization of the stent delivery system. Borders of loaded stents were clearly marked, which allowed precise stent placement in all experiments. Balanced fast field-echo MR imaging and contrast-enhanced MR angiography provided information about immediate postintervention position. Positions depicted on MR images were found accurate at postmortem examination. Results of Bland-Altman analysis showed good agreement between blood flow velocities measured in and next to the stent lumen, with a mean difference of -9 cm/sec +/- 5 (standard deviation). CONCLUSION: Resonant circuits are well suited for use at deployment of endovascular stents.


Asunto(s)
Cateterismo/instrumentación , Imagen por Resonancia Magnética , Radiología Intervencionista , Stents , Aleaciones , Animales , Aorta/anatomía & histología , Aorta Abdominal/anatomía & histología , Velocidad del Flujo Sanguíneo/fisiología , Arteria Carótida Común/anatomía & histología , Medios de Contraste , Espectroscopía de Resonancia por Spin del Electrón/instrumentación , Diseño de Equipo , Arteria Ilíaca/anatomía & histología , Angiografía por Resonancia Magnética , Imagen por Resonancia Cinemagnética , Porcinos , Vena Cava Inferior/anatomía & histología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA